WebJul 26, 2024 · There are good investments and there are great investments. CRISPR Therapeutics (CRSP 1.32%) stock certainly qualifies as the latter.. This is a company … WebOct 9, 2024 · CRISPR Therapeutics closed Thursday at $95.39. The stock is up 57 percent this year but is still trading 10 percent below its 52-week high. Meanwhile, Beam Therapeutics stock closed Thursday at ...
CRISPR Stocks to Invest In Learn More Investment U
Web18 hours ago · Cathie Wood purchased 56,942 shares of Crispr Therapeutics yesterday.; Today, the gene-editing company received a price target of $72 from Cantor Fitzgerald. CRSP stock is up by over 20% year-to-date. WebJan 28, 2024 · Should You Invest in CRISPR? CRISPR is a technology that can be used to edit genes and presents a plethora of possibilities in many industries. But none more so … north eastern episcopal district
Why Shares of CRISPR Therapeutics Jumped Thursday
WebApr 7, 2024 · Currently, Ginkgo Bioworks Holdings Inc does not have a price-earnings ratio. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $477.7 million with a -440.6% net profit margin. Year-over-year quarterly sales growth most recently was -33.8%. Analysts expect adjusted earnings to reach $-0.345 per share for the current fiscal year. WebApr 6, 2024 · Fintel reports that on April 13, 2024, Cantor Fitzgerald initiated coverage of Crispr Therapeutics (NASDAQ:CRSP) with a Overweight recommendation. As of April 6, … Web23 hours ago · Market Cap. $84B. Today's Change. (2.14%) $6.98. Current Price. $333.35. Price as of April 13, 2024, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley ... northeastern epilepsy group